Blocking the PD-1 signal restores cytokine release (IFN-γ, Tumor Necrosis Factor (TNF), Interleukin 2) and preserves a pool of memory T-cells that sustains long-term tumor control [34,35,36]. Here, PDCD1 is linked to neoplasm.